Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07394270
PHASE2

Effect of Add-on L-Arginine Therapy on Heart Failure Patients

Sponsor: German University in Cairo

View on ClinicalTrials.gov

Summary

Heart failure is considered one of the greatest challenges globally. There are various treatment strategies for heart failure. L-Arginine is an amino acid that was found to have beneficial effect on vasculature. This study aims to study the benefits and side effects of using L-arginine on the patients with ejection fraction \<40%

Official title: Effect of Add-on L-Arginine Therapy on Clinical Outcome of Heart Failure Patients: A Randomized- Controlled Trial

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2026-02

Completion Date

2027-07

Last Updated

2026-02-06

Healthy Volunteers

No

Conditions

Interventions

DRUG

L-Arginine Powder

L-arginine 3 gm sachets are used twice daily

DRUG

Placebo

2 sachets of placebo are administered per day

Locations (1)

Ain Shams University

Cairo, Egypt